AnaptysBio, Inc. (ANAB)

50.37 +0.33 (+0.66%) USD  |  NASDAQ  |  Dec 24, 10:51
More

AnaptysBio SG&A Expense (TTM): 45.14M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. 214.26M
Ovid Therapeutics, Inc. 22.56M
Ionis Pharmaceuticals, Inc. 351.68M
CorMedix, Inc. 75.56M
Verastem, Inc. 67.48M